Vaccinology

G. Dranoff, E. Jaffee, A. Lazenby, P. Golumbek, H. Levitsky, K. Brose, V. Jackson, H. Hamada, D. Pardoll, R.C. Mulligan, "Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity," Proceedings of the National Academy of Sciences, 90:3539-43, 1993. (Cited in 170 publications through May 1995) Comments by Glenn Dranoff, Dana-Farber Cancer Institute and Harvard Medical Sc

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Comments by Glenn Dranoff, Dana-Farber Cancer Institute and Harvard Medical School, Boston

"While the notion of the development of cancer vaccines is quite old--going back almost a century, in fact--clinical experience in the field has in most cases been disappointing," observes Glenn Dranoff, an assistant professor of medicine at the Dana- Farber Cancer Institute and Harvard Medical School. "However, modern ad-vances, such as gene-transfer technologies and the ability to clone cytokine genes, have given us the means to test the possibilities of cancer vaccines in new ways which were not possible before.

"The idea that engineering tumor cells to produce cytokines might impact on the host's response to the tumors was first suggested in the late 1980s," he recounts. "An early study showed tumor cells engineered to produce interleukin-4 [IL-4] were rejected when injected back into the host [R. Tepper et al., Cell, 57:503- 12, 1989]. Yet another study showed ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Neeraja Sankaran

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio